GI & Endoscopy

Patients undergoing proton pump inhibitor therapy face an increased risk of acute kidney injury and acute interstitial nephritis, according to a study in CMAJ Open.

Analysts with RBC Capital have increased their price target of Boston Scientific to $20, according to a report by The Legacy.

Here are the five most popular GI/endoscopy articles on Becker's ASC Review for the week of April 13 to April 17.

Aiken (S.C.) Regional Medical Centers has added two new gastroenterology service lines, according to an Aiken Standard report.

Colorectal cancer screening leads the cancer prevention conversation in the GI field, but other types of GI cancer are also on the rise. A new study published in Clinical Gastroenterology and Hepatology examines screening for Barrett's esophagus and esophageal adenocarcinoma.…

Here is a stock report on five publicly traded GI/endoscopy companies for April 13 to April 17.

One gastroenterologists shares his experience of practicing outside the traditional payer-based payment model.

Here are seven news updates for gastroenterologists to know for April 17, 2015.

Here are three gastroenterologists who were featured in the news within the past week.

CMS has released new guidance on two different coding modifiers, according to an AGA eDigest report.